MARKER THERAPEUTICS, INC. Current Federal Tax Expense (Benefit)
MARKER THERAPEUTICS, INC. (MRKR) reported Current Federal Tax Expense (Benefit) of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentFederalTaxExpenseBenefit · last filed 2026-03-18
- MARKER THERAPEUTICS, INC. current federal tax expense (benefit) for fiscal 2025 was $0.00.
- MARKER THERAPEUTICS, INC. current federal tax expense (benefit) for fiscal 2024 was $0.00.
- MARKER THERAPEUTICS, INC. current federal tax expense (benefit) for fiscal 2023 was $0.00.
- MARKER THERAPEUTICS, INC. current federal tax expense (benefit) for fiscal 2022 was $0.00.
| Period end | Current Federal Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-18 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-18 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-31 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |